Medicare Enrolled
Tanya Marr, FNP
Nurse Practitioner - Family · Utica, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Marr from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Marr?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Marr
Tanya Marr is a nurse practitioner - family in Utica, NY, with 13 years of NPI registration. Based on federal Medicare data, Marr performed 598 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Marr received a total of $9,204 from 69 pharmaceutical and/or device companies across 506 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Marr is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 19% volume in NY
$9,204 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗598
Medicare services
Top 19% in NY for nurse practitioner - family
Not available
Unique patients (not deduplicated)
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
399 | $60 | $179 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $46 | $174 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $99 | $266 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $67 | $229 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
15 | $35 | $100 |
| New patient office visit, complex (60-74 min) | 14 | $119 | $323 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
12 | $6 | $120 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
11 | $2 | $10 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
11 | $40 | $131 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,204
Total received (2021-2024)
Avg $2,301/year across 4 years
Top 1% in NY for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
506
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,800
2023
$2,374
2022
$2,993
2021
$2,037
Payments by company (2024)
Daiichi Sankyo Inc.
$265
Janssen Biotech, Inc.
$225
Novartis Pharmaceuticals Corporation
$194
ADC Therapeutics America, Inc.
$149
Merck Sharp & Dohme LLC
$101
Incyte Corporation
$77
AstraZeneca Pharmaceuticals LP
$65
Regeneron Healthcare Solutions, Inc.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$63
Ipsen Biopharmaceuticals, Inc
$59
Eisai Inc.
$48
ABBVIE INC.
$41
PFIZER INC.
$41
Genentech USA, Inc.
$40
Myriad Genetic Laboratories, Inc.
$39
Gilead Sciences, Inc.
$37
Celgene Corporation
$36
Exelixis Inc.
$34
Lilly USA, LLC
$26
Coherus Biosciences Inc.
$25
Stemline Therapeutics Inc.
$22
Aveo Pharmaceuticals, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$20
Bayer Healthcare Pharmaceuticals Inc.
$17
E.R. Squibb & Sons, L.L.C.
$17
Karyopharm Therapeutics Inc.
$16
Astellas Pharma US Inc
$16
Blueprint Medicines Corporation
$15
BeiGene USA, Inc.
$14
SpringWorks Therapeutics, Inc.
$14
Top 3 companies account for 38.0% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$938
Amgen Inc.
$569
E.R. Squibb & Sons, L.L.C.
$501
Janssen Biotech, Inc.
$490
Daiichi Sankyo Inc.
$463
AstraZeneca Pharmaceuticals LP
$427
Astellas Pharma US Inc
$345
GENZYME CORPORATION
$340
Incyte Corporation
$303
Pharmacyclics LLC, An AbbVie Company
$294
Celgene Corporation
$290
PFIZER INC.
$282
SANOFI-AVENTIS U.S. LLC
$267
Takeda Pharmaceuticals U.S.A., Inc.
$262
Merck Sharp & Dohme LLC
$250
Lilly USA, LLC
$239
Genentech USA, Inc.
$208
Regeneron Healthcare Solutions, Inc.
$202
Myriad Genetic Laboratories, Inc.
$190
ADC Therapeutics America, Inc.
$168
Epizyme, Inc.,
$155
Seagen Inc.
$152
Blueprint Medicines Corporation
$97
Gilead Sciences, Inc.
$93
GlaxoSmithKline, LLC.
$90
Eisai Inc.
$86
Exelixis Inc.
$81
Kyowa Kirin, Inc.
$80
ARRAY BIOPHARMA INC
$69
Pharmacyclics LLC, an AbbVie Company
$67
EMD Serono, Inc.
$63
Ipsen Biopharmaceuticals, Inc
$59
ABBVIE INC.
$58
Pharmacosmos Therapeutics Inc.
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Karyopharm Therapeutics Inc.
$48
Merck Sharp & Dohme Corporation
$47
Mirati Therapeutics, Inc.
$47
Genmab U.S., Inc.
$45
Rigel Pharmaceuticals, Inc.
$44
G1 Therapeutics, Inc.
$41
PUMA BIOTECHNOLOGY, INC.
$39
Bayer HealthCare Pharmaceuticals Inc.
$39
JAZZ PHARMACEUTICALS INC.
$38
Coherus Biosciences Inc.
$38
Aveo Pharmaceuticals, Inc.
$38
Taiho Oncology, Inc.
$37
AVEO Pharmaceuticals, Inc.
$36
Janssen Pharmaceuticals, Inc
$32
MorphoSys, US Inc.
$31
ARGENX US, INC.
$23
Stemline Therapeutics Inc.
$22
Alexion Pharmaceuticals, Inc.
$22
Apellis Pharmaceuticals, Inc.
$21
TerSera Therapeutics LLC
$20
Deciphera Pharmaceuticals Inc.
$18
TAIHO ONCOLOGY, INC.
$18
Bayer Healthcare Pharmaceuticals Inc.
$17
CTI BioPharma Corp.
$17
Myovant Sciences Inc.
$16
Octapharma USA, Inc.
$15
Dendreon Pharmaceuticals LLC
$15
Sobi, Inc
$14
BeiGene USA, Inc.
$14
Puma Biotechnology, Inc.
$14
SpringWorks Therapeutics, Inc.
$14
Global Blood Therapeutics, Inc.
$13
AbbVie Inc.
$12
Clovis Oncology, Inc.
$7
Top 3 companies account for 21.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Columvi · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · Monoferric · NERLYNX · NINLARO · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TUKYSA · Tecentriq · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VYVGART · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family nurse practitioners in nearby ZIP areas
272
County median income
$68,819
Nearest hospital to ZIP centroid (approximate)
MOHAWK VALLEY PSYCHIATRIC CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Marr is a clinical cardiology specialist, with above-average Medicare volume (top 19% in NY).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Marr experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Marr performed 399 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Marr receive payments from pharmaceutical companies?
Yes. Marr received a total of $9,204 from 69 companies across 506 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Marr's costs compare to other family nurse practitioners in Utica?
Marr's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Marr) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Utica
Browse family nurse practitioners in Utica ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in NY
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in NY
Which NY family nurse practitioners receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology